Metastatic Cervical Cancer
20 clinical trials · Condition
◉ Watch Metastatic Cervical Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer (NCT04380805) | Akeso | 2020-07-15 |
| Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer (NCT04230954) | University of South Alabama | 2020-04-16 |
| HER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib (NCT03786107) | Puma Biotechnology, Inc. | 2019-03-14 |
| SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer (NCT03816553) | Sun Yat-sen University | 2019-01-19 |
| Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer (NCT04266886) | M.D. Anderson Cancer Center | 2018-09-11 |
| Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer (NCT03277482) | Dana-Farber Cancer Institute | 2018-06-01 |
| Hydralazine Valproate for Cervical Cancer (NCT00532818) | National Institute of Cancerología | 2007-07-01 |
Track Metastatic Cervical Cancer automatically
Every clearance here is in the API, with alerts when new ones post.